Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
Clinical trial NCT00256828 · COMPLETED
Trial details
- NCT number
- NCT00256828
- Sponsor
- Clinical Trial Agency of HIV Study Group
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.